Plus   Neg

PDL BioPharma Inc. Q1 Income Climbs

PDL BioPharma Inc. (PDLI) released earnings for its first quarter that climbed from last year.

The company's bottom line totaled $6.68 million, or $0.05 per share. This compares with $1.60 million, or $0.01 per share, in last year's first quarter.

Analysts had expected the company to earn $0.08 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 1.0% to $38.91 million from $38.52 million last year.

PDL BioPharma Inc. earnings at a glance:

-Earnings (Q1): $6.68 Mln. vs. $1.60 Mln. last year.
-EPS (Q1): $0.05 vs. $0.01 last year.
-Analysts Estimate: $0.08
-Revenue (Q1): $38.91 Mln vs. $38.52 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT